BNGO says OGM adoption accelerates amid validation and reimbursement
Optical genome mapping is rapidly replacing traditional cytogenetic methods, with strong global clinical validation and expanding reimbursement. Strategic focus on recurring revenue and operational efficiency has improved margins, with projections for significant revenue growth and EBITDA breakeven…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.